[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341192-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341192-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","integrating-bioinformatics-and-experimental-models-to-investigate-the-mechanism-of-chelidonine-induced-mitotic-catastrophe-via-aktfoxo3foxm1-axis-in-breast-cancer-cells-research-article","Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells - research article","","Breast cancer is a leading cause of cancer-related mortality in women, making new biomarkers and anticancer candidates essential. Chelidonine, an active ingredient from Chelidonium majus, was evaluated for its ability to trigger mitotic catastrophe in breast cancer cells and to define its underlying mechanism via the AKT/FOXO3/FOXM1 pathway. Bioinformatics showed FOXO3 downregulation across subtypes and linked higher FOXO3 to better overall and relapse-free survival, while FOXM1 correlated negatively with outcomes. Experimental assays demonstrated chelidonine suppressed proliferation, induced M phase arrest, promoted apoptosis with survivin reduction, enhanced p53 and caspase-9 expression, and produced mitotic catastrophe phenotypes. Western blotting indicated inhibition of p-AKT with FOXO3 upregulation and FOXM1/PLK1 weakening, supporting FOXO3 as a predictive biomarker and therapeutic target and chelidonine as a promising agent.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/integrating-bioinformatics-and-experimental-models-to-investigate-the-mechanism-of-chelidonine-induced-mitotic-catastrophe-via-aktfoxo3foxm1-axis-in-breast-cancer-cells-research-article/341192/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/integrating-bioinformatics-and-experimental-models-to-investigate-the-mechanism-of-chelidonine-induced-mitotic-catastrophe-via-aktfoxo3foxm1-axis-in-breast-cancer-cells-research-article/341192.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s main goal regarding chelidonine in breast cancer?","Question",{"text":63,"@type":64},"To determine whether chelidonine can trigger mitotic catastrophe in breast cancer cells and to clarify the mechanism through the AKT/FOXO3/FOXM1 pathway.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were FOXO3 and FOXM1 related to breast cancer prognosis?",{"text":68,"@type":64},"Bioinformatics showed FOXO3 downregulation in breast cancer subtypes and that higher FOXO3 expression associated with better overall survival and relapse-free survival. FOXM1 levels correlated negatively with both overall and relapse-free survival.",{"name":70,"@type":61,"acceptedAnswer":71},"What cellular effects did chelidonine produce in breast cancer cells?",{"text":72,"@type":64},"Chelidonine inhibited proliferation, induced M phase arrest, promoted apoptosis, reduced survivin, increased p53 and caspase-9, and produced mitotic catastrophe characteristics such as abnormal mitosis and multinucleated cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341192,1791068711,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","RESEARCH ARTICLE  \nIntegrating bioinformatics and experimental models to investigate the mechanism ofthe chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells  \nHuimin Li 1, Xiyu Tang 1, Zhiwei Sun 2, Zhongyuan Qu 1 ∗ , and Xiang Zou 2 ∗  \nBreast cancer (BC) is currently the most frequent and lethal cancer among women, and therefore, identification of novel biomarkers and potential anticancer agents for BC is crucial. Chelidonine is one of the main active ingredients of Chelidonium majus, which has been applied in Chinese medicine prescriptions to treat cancer. This paper aimed to evaluate the ability of chelidonine to trigger mitotic catastrophe in BC cells and to clarify its mechanism through the AKT/FOXO3/FOXM1 pathway. Bioinformatics analysis revealed that forkhead box O3 (FOXO3) was downregulated in different subtypes of BC. Factors, such as age, stage, Scarff–Bloom–Richardson (SBR) grade, diverse BC subclasses, and triple-negative status, were inversely correlated to FOXO3 levels in BC patients compared with healthy controls. Notably, patients exhibiting higher FOXO3 expression levels demonstrated better overall survival (OS) and relapse-free survival (RFS) . Moreover, FOXM1 levels were negatively correlated with both OS and RFS in BC patients. These results revealed that FOXO3 might be considered a predictive biomarker for the prognosis of BC. By utilizing Gene Set Enrichment Analysis (GSEA), we delved into the main Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment pathways of FOXO3, and the results suggested that FOXO3 was mainly involved in cancer-related pathways and the cell cycle. Thereafter, MTT and flow cytometry (FCM) analysis indicated that chelidonine inhibited BC cell line proliferation and induced M phase arrest. It was found that chelidonine treatment induced MCF-7 cell apoptosis, significantly reduced the expression of survivin and promoted the expression of p53 and caspase-9 . Further morphological observation illustrated depolymerization of the actin skeleton and shortening of actin filaments in BC cells, leading to the typical characteristics of mitotic catastrophe, such as abnormal mitosis and multinucleated cells. Western blot analysis demonstrated that chelidonine inhibited the expression of p-AKT to promote the expression of FOXO3 protein and weaken the expression levels of FOXM1 and polo-like kinase 1 (PLK1). Taken together, our present work proved that FOXO3 might be considered a potential therapeutic target for BC. Chelidonine emerges as a promising agent to treat BC by inducing M phase arrest of BC cells and hindering the AKT/FOXO3/FOXM1 axis, thereby inducing mitotic catastrophe in BC.  \nKeywords: Chelidonine, breast cancer (BC), AKT/FOXO3/FOXM1 axis, cell cycle arrest, mitotic catastrophe.  \nIntroduction  \nThe most frequently diagnosed cancer and the leading cause of mortality for women globally is breast cancer (BC) [1] . The majority of new tumorsin women, approximately 30%, are BCs, according to the mostrecent epidemiological data [2]. The onset of BC is insidious; early lesions are hard to ﬁnd and distant metastasis of tumor cells can cause damage and pathological changes in multiple organs. However, as an increasing number of targets and related medications are being developed, there have been great advances in the treatment and prognosis of BC [3, 4] .  \nThe convergence point of the complicated oncogenic signaling network is downstream of the cell cycle, and its deregulation  \nis central to the abnormal cell proliferation that characterizes all cancers [5]; therefore, the cell cycle presents a potential target for cancer diagnostics and treatment. Genomic changes throughout the cell cycle cause genomic instability, which is present at diﬀerent phases of cancer development and is a feature of almost all malignancies [6] . When mitosis is incomplete or fails, a controlled anti-proliferative mechanism known as mitotic catastrophe occurs [7] . Mi","cbCairfhwESRh63P","https://ap.wps.com/l/cbCairfhwESRh63P","pdf",9886909,15,"English","# Introduction\n## Breast cancer burden and need for biomarkers\n## Cell cycle as a therapeutic target\n## Mitotic catastrophe and its relevance\n## FOXO proteins and FOXO3/FOXM1 roles\n## AKT/FOXO3/FOXM1 signaling rationale\n# Materials and Methods\n## Bioinformatics analysis approach\n## Cell viability and proliferation assays\n## Flow cytometry for cell cycle and apoptosis\n## Morphological observations\n## Western blot detection\n# Results\n## FOXO3 expression patterns and clinical correlations\n## KEGG enrichment and FOXO3-associated pathways\n## Chelidonine effects on proliferation and M phase arrest\n## Apoptosis markers and survivin/p53/caspase-9 changes\n## Mitotic catastrophe morphology and actin alterations\n## AKT/FOXO3/FOXM1 axis modulation by chelidonine\n# Discussion","[{\"question\":\"What was the study’s main goal regarding chelidonine in breast cancer?\",\"answer\":\"To determine whether chelidonine can trigger mitotic catastrophe in breast cancer cells and to clarify the mechanism through the AKT/FOXO3/FOXM1 pathway.\"},{\"question\":\"How were FOXO3 and FOXM1 related to breast cancer prognosis?\",\"answer\":\"Bioinformatics showed FOXO3 downregulation in breast cancer subtypes and that higher FOXO3 expression associated with better overall survival and relapse-free survival. FOXM1 levels correlated negatively with both overall and relapse-free survival.\"},{\"question\":\"What cellular effects did chelidonine produce in breast cancer cells?\",\"answer\":\"Chelidonine inhibited proliferation, induced M phase arrest, promoted apoptosis, reduced survivin, increased p53 and caspase-9, and produced mitotic catastrophe characteristics such as abnormal mitosis and multinucleated cells.\"}]","Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells - research article | PDF",1790040817,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ba96ea297be4ec0b72bbc7b34737ad4.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c304e17f9e84ae32e3bac1ee8e3cc814.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2bdf279d2a109b2ecf9a3cf6874b456a.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/227c2dd60ba6356acf87348a1cbb795c.webp",980,1268]